...
首页> 外文期刊>Acta Radiologica >Comparison of monoexponential, intravoxel incoherent motion diffusion-weighted imaging and diffusion kurtosis imaging for assessment of hepatic fibrosis
【24h】

Comparison of monoexponential, intravoxel incoherent motion diffusion-weighted imaging and diffusion kurtosis imaging for assessment of hepatic fibrosis

机译:单烯烃型椎间杂环型运动扩散加权成像对肝纤维化评估

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Hepatic fibrosis is a dynamic, reversible process which can result in liver failure. Diagnosis and monitoring of hepatic fibrosis are clinically important. Purpose To compare the diagnostic performance of diffusion kurtosis imaging (DKI), intravoxel incoherent motion (IVIM), and monoexponential diffusion-weighted imaging (DWI) to detect clinically significant fibrosis (>= F2). Material and Methods This retrospective study was approved by Institutional Review Board and the requirement of informed consent was waived. One hundred and six patients were included who underwent liver multiple b-value DWI (10 b-values at 0-1000 s/mm(2)) at 1.5 T and were histologically diagnosed with hepatic fibrosis. Apparent diffusion coefficient (ADC), DKI-derived apparent kurtosis (Kapp) and diffusivity (Dapp), and IVIM-derived true diffusion (Dt), pseudodiffusion (D*), and perfusion fraction (f) were compared between no or early fibrosis (F0-1, n = 19) and clinically significant fibrosis (>= F2, n = 87). Diagnostic performance was evaluated with receiver operating characteristic (ROC) analysis. Results F2-4 had a significantly lower D* (59.9 +/- 16.3 vs. 86.2 +/- 21.0 [x10(-3) mm(2)/s]) and Dapp (3.46 +/- 0.79 vs. 4.07 +/- 0.76 [x10(-3) mm(2)/s]) but higher Kapp (1.10 +/- 0.18 vs. 0.98 +/- 0.12) than F0-1 (P 0.05). The area under the ROC curve for diagnosis of clinically significant fibrosis (>= F2) was significantly larger in D* (0.89; 95% CI = 0.81-0.94) than Dapp (0.73; 95% CI = 0.63-0.81) and Kapp (0.75; 95% CI = 0.65-0.83) (P = 0.017 and 0.012, respectively). Conclusion IVIM-DWI might be more suitable for detecting hepatic fibrosis than the monoexponential and kurtosis model, and D* showed a better diagnostic performance to detect clinically significant fibrosis than other parameters.
机译:背景技术肝纤维化是一种动态,可逆的过程,可能导致肝功能衰竭。肝纤维化的诊断和监测在临床上很重要。目的,用于比较扩散峰峰成像(DKI),椎间克利克隆的运动(IVIM)和单值扩散加权成像(DWI)来检测临床显着纤维化(> = F2)的诊断性能。材料和方法本回顾性研究由机构审查委员会批准,并放弃了知情同意的要求。包括在1.5 T处接受肝多数B值DWI(10b值)的肝脏多个B值DWI(10b值)的患者,并在肝纤维化术后组织学诊断。在NO或早期纤维化之间比较了表观扩散系数(ADC),DKI衍生的表观峰(KAPP)和扩散性(DT),伪分裂(DT),假序列(F) (F0-1,N = 19)和临床显着的纤维化(> = F2,n = 87)。通过接收器操作特征(ROC)分析评估诊断性能。结果F2-4具有显着降低的D *(59.9 +/- 16.3与86.2 +/- 21.0 [x10(-3)mm(2)/ s])和dapp(3.46 +/- 0.79与4.07 + / - 0.76 [x10(-3)mm(2)/ s])但高于kapp(1.10 +/- 0.18与0.98 +/- 0.12),而不是f0-1(p 0.05)。用于诊断临床显着纤维化(> = F2)的ROC曲线下的面积比DAPP在D *(0.89; 95%CI = 0.81-0.94)中显着较大(0.73; 95%CI = 0.63-0.81)和KAPP( 0.75; 95%CI = 0.65-0.83)(分别为P = 0.017和0.012)。结论IVIM-DWI可能更适合于检测肝纤维化,而不是单烯烃突变模型,D *显示出更好的诊断性能,以检测临床显着纤维化的纤维化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号